IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Participant Enrollment Begins for Phase 1 Trial of IAVI-Merck COVID-19 Vaccine Candidate

November 6, 2020

The study will assess the safety, tolerability, and immunogenicity of SARS-CoV-2 vaccine candidate V590 compared to placebo.

Read more

Scientific Publications

Prevalence and correlates of HIV infection among adolescents and young people living in fishing populations along Lake Victoria Fishing Communities in Uganda

Read more

Press Releases

IAVI Announces Start of Clinical Trial of Next-Generation HIV Vaccine Candidate

October 29, 2020

Aim is production of precursors to broadly neutralizing antibodies.

Read more

Press Releases

Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says

October 27, 2020

NEW YORK — OCTOBER 27, 2020 — IAVI announced today the award of US$26.7M from the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to support IAVI’s recombinant vesicular stomatitis virus (rVSV) vectored SARS-CoV-2 vaccine candidate. DTRA’s commitment will enable critical nonclinical development on the vaccine candidate that IAVI is developing…

Read more

Features

Progress Toward Global Access to Affordable Antibodies

October 23, 2020

There are more than 70 different mAbs in various stages of development for the treatment and prevention of COVID-19, including those discovered by a team of scientists including investigators from IAVI and Scripps Research.

Read more

Press Releases

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

October 22, 2020

Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response.

Read more

In The News

Scientists build on HIV research in bid to stop snakebite deaths

Devex

October 21, 2020

Read more

Features

What are monoclonal antibodies, and can they treat COVID-19?

October 8, 2020

Monoclonal antibodies have changed the way we treat many diseases. They are a promising treatment for COVID-19, and IAVI is committed to developing SARS-CoV-2 antibodies that will be globally accessible. 

Read more